← Back to Search

Behavioural Intervention

Virtual reality-directed BGBT for Inflammatory Bowel Disease

N/A
Recruiting
Led By Shirley Cohen-Mekelburg, MD, MS
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week (semi-structured interview within 1 week of completion of the intervention)
Awards & highlights

Study Summary

This trial is investigating the use of virtual reality therapy for patients with inflammatory bowel disease who are in the hospital. The goal is to see if this type of therapy is feasible and well-received for managing

Who is the study for?
This trial is for hospitalized patients with Inflammatory Bowel Disease (IBD) who are interested in trying a new pain treatment. The study will test if a Virtual Reality (VR)-directed therapy can help manage their pain while they're in the hospital.Check my eligibility
What is being tested?
The intervention being studied is a VR-directed brain-gut behavioral therapy (BGBT). It's designed to see if using VR technology can be an effective way to treat pain for IBD patients during their hospital stay.See study design
What are the potential side effects?
Since this trial involves non-invasive virtual reality therapy, there may not be typical medication side effects. However, participants might experience discomfort from wearing the VR headset or motion sickness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week (semi-structured interview within 1 week of completion of the intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week (semi-structured interview within 1 week of completion of the intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of the intervention measured as the frequency (percentage) of enrolled participants that complete the VR-directed BGBT inpatient program
Secondary outcome measures
Acceptability using the System Usability Scale - patients
Acceptability using the Treatment Acceptance and Adherence Scale- patients
Intervention acceptability based on qualitative data and collected from audio-recordings of semi-structured interview

Trial Design

1Treatment groups
Experimental Treatment
Group I: Virtual reality-directed BGBTExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,798 Previous Clinical Trials
6,378,098 Total Patients Enrolled
Shirley Cohen-Mekelburg, MD, MSPrincipal InvestigatorUniversity of Michigan

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants currently being recruited for this ongoing medical study?

"According to the data available on clinicaltrials.gov, this specific trial is not currently accepting new participants. The trial was initially listed on January 1st, 2024, and its most recent update was made on December 18th, 2023. However, it's worth noting that there are presently a total of 189 other active clinical trials actively seeking participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients
Shirley Cohen-Mekelburg 2024. "Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06188793.
All > Inflammatory Bowel Disease > Ibd
~27 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top